Medicines Australia welcomes the Australian Government’s plans to improve access to medicines and medical devices by cutting unnecessary red tape.

Medicines Australia CEO, Tim James, has further supported the Government’s proposal to examine whether the Therapeutic Goods Administration should introduce fast-track approvals and reduce the regulatory burden on manufacturers.

“Australia has a world class regulator in the TGA and timely, targeted re-analysis and improvement is a hallmark of that quality. Full marks to the Government in selecting three very distinguished experts in Will Delaat, Lloyd Sansom and John Horvath to undertake this review,” Mr James said.

“This industry has no doubt that they will conduct a full, frank and fair assessment of the regulatory processes in Australia and make sound recommendations on how to further update Australia’s regulatory system.

“We are encouraged by the actions of the Government to date, in its commitment to ease the thicket of red tape around making drugs and medical devices available to Australians as rapidly as possible.

“Medicines Australia has already been actively engaged with Government to reduce unnecessary regulation and cut red tape in the medicines industry.

For more details, go to: http://medicinesaustralia.com.au/2014/10/24/ma-welcomes-government-proposal-to-cut-medical-red-tape/